— Why it moved
Why BJDX Stock Nearly Quadrupled Today — June 2, 2026
A manufacturing partnership press release met a 2.4M-share float, ran Bluejay from $2.17 to $8.48 before the bell, and half the peak was gone by the close.
What moved it
Bluejay announced a strategic manufacturing partnership with Argonaut Manufacturing Services for its Symphony sepsis-testing platform. A scale-up press release with no revenue attached.
The mechanics
This was a ~$2M market cap with a 2.35M-share float, about as small as a listed company gets. One headline plus scanner attention turned that float into a slingshot. 74M shares traded against a 55K daily average, meaning the float changed hands roughly 31 times.
Numbers
- Cap: ~$2M at the prior close / float: 2.35M
- Day volume: 74M (the 30-day average was 55K)
- Prev close: $2.17 → $8.48 premarket high
- 52w range: $1.62–$16.68, already down 87% from the high before this move
Where it ended up
Stock Pulse flagged it at 6:52 AM premarket at $6.95. Twenty-six minutes later it hit $8.48, up 22% from the alert, on real volume. That 7:18 AM print was the high of the entire day. The regular session never traded above $7.00, and it closed at $4.31, 38% below the alert.
Reality check
- Alert to close was -38%. Peak to close, the stock lost half its value.
- Symphony is still in clinical development, and Bluejay has leaned on reverse splits to hold its listing.
- This is a breakdown of a premarket blowoff, not an idea.